Granulocyte-macrophage colony-stimulating factor is a key mediator in inflammatory and arthritic pain.
about
A standardized blood test for the routine clinical diagnosis of impaired GM-CSF signaling using flow cytometry.MOR103, a human monoclonal antibody to granulocyte-macrophage colony-stimulating factor, in the treatment of patients with moderate rheumatoid arthritis: results of a phase Ib/IIa randomised, double-blind, placebo-controlled, dose-escalation trial.The effect of interleukin 17 and Toll-like receptor 2 on CD11b expression and apoptosis of neutrophils in zymosaninduced arthritis and paw oedema.Dynamic weight bearing is an efficient and predictable method for evaluation of arthritic nociception and its pathophysiological mechanisms in mice.Granulocyte-macrophage colony-stimulating factor is a key mediator in experimental osteoarthritis pain and disease development.Characterization of pathogenic human monoclonal autoantibodies against GM-CSF.Early clearance of Chikungunya virus in children is associated with a strong innate immune response.A (selective) history of Australian involvement in cytokine biology.Granulocyte macrophage colony-stimulating factor induces CCL17 production via IRF4 to mediate inflammationGranulocyte macrophage colony-stimulating factor receptor α expression and its targeting in antigen-induced arthritis and inflammationDifferential expression of CD148 on leukocyte subsets in inflammatory arthritis.Phase 1b randomized, double-blind study of namilumab, an anti-granulocyte macrophage colony-stimulating factor monoclonal antibody, in mild-to-moderate rheumatoid arthritis.GM-CSF as a target in inflammatory/autoimmune disease: current evidence and future therapeutic potential.Targeting GM-CSF in inflammatory diseases.Selected cytokine pathways in rheumatoid arthritis.G-CSF Receptor Blockade Ameliorates Arthritic Pain and Disease.Activation-dependent cell death of human monocytes is a novel mechanism of fine-tuning inflammation and autoimmunity.Granulocyte-macrophage colony-stimulating factor (GM-CSF) is released by female mouse bladder urothelial cells and expressed by the urothelium as an early response to lipopolysaccharides (LPS).Human Adipose-Derived Mesenchymal Stem Cells Modulate Experimental Autoimmune Arthritis by Modifying Early Adaptive T Cell Responses.Alterations in the Secretome of Clinically Relevant Preparations of Adipose-Derived Mesenchymal Stem Cells Cocultured with Hyaluronan.Adipose-derived mesenchymal stromal cells modulate experimental autoimmune arthritis by inducing an early regulatory innate cell signature.Transcriptional mechanisms underlying sensitization of peripheral sensory neurons by granulocyte-/granulocyte-macrophage colony stimulating factors.GM-CSF as a therapeutic target in autoimmune diseases.Central inhibition of granulocyte-macrophage colony-stimulating factor is analgesic in experimental neuropathic pain.Investigational therapies targeting the granulocyte macrophage colony-stimulating factor receptor-α in rheumatoid arthritis: focus on mavrilimumab.Increased Frequency of Peripheral B and T Cells Expressing Granulocyte Monocyte Colony-Stimulating Factor in Rheumatoid Arthritis Patients.CCL17 blockade as a therapy for osteoarthritis pain and disease.TNF and granulocyte macrophage-colony stimulating factor interdependence mediates inflammation via CCL17.
P2860
Q35078403-3A4BB451-3C56-4296-8EE8-DD7E44B98F8DQ35605418-2D924F85-ADAB-4B44-B6FD-3475381FDC4FQ35631906-85D1E4E3-D64C-44EA-A055-77F842FAD036Q36221651-5CD30BD7-A0D0-4A59-B3E6-AF0639FD645CQ36633120-D36849A8-F7A8-4244-9D00-AC9F695C91DBQ36835759-A80B4B9A-A825-46C4-AF8C-BBA6E06824B1Q36903227-C44448F3-3DEA-48A7-8655-CB31A2A83DD0Q37018307-4F5F4360-BD89-4949-BF8F-8274F1B08657Q37217530-9363434D-F44A-4242-877F-4D57C8F138BBQ37466119-3798A37D-3EBA-42E9-993F-F615140F70D1Q37689769-D69A717D-DDF2-427D-A1F9-C199C5F48D0FQ37690033-8C7C875B-5EF3-43A3-9A2D-569F7534819DQ38369816-C97E057F-45D2-4717-B9DF-5798C8C0FE2EQ38657999-8B140B11-6EA7-4685-BEA6-6BC6EE92A621Q38755912-F3F7A429-0EC7-49CE-98AF-FB55FCC67181Q38892537-9E06AF52-B35B-49AB-A9A6-79922525B24AQ39783478-D98787DB-E9DB-4394-AC5A-A4FD356A405BQ40639060-45973C2D-55F1-45F3-BF47-9B522203A144Q40702107-E1E65BDE-6B5D-4BE3-9104-A9CCDC6893B8Q42040579-056D4ACB-C65D-422B-9F2C-4D41446F72EEQ42763577-4318D26B-C5FF-41FB-A53F-64E7268F3370Q42844654-2DDDD45D-9BD9-44D7-9F12-FE39CD8FA440Q47138480-493794BB-B584-43F3-84DA-7B952F6BA590Q47652745-DD6183F2-C532-4872-9D32-95FBEE2255C7Q49393096-D1D41D4F-A321-4D44-B601-605500CDBFA5Q49630708-4FB51650-C4F6-4EA2-AC5D-518D71715CBDQ52604134-9792D71F-5467-44D7-8130-15F4274AF653Q52644010-E44A646E-D372-4DD8-8E84-1D8F3FE9A359
P2860
Granulocyte-macrophage colony-stimulating factor is a key mediator in inflammatory and arthritic pain.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年学术文章
@wuu
2012年学术文章
@zh
2012年学术文章
@zh-cn
2012年学术文章
@zh-hans
2012年学术文章
@zh-my
2012年学术文章
@zh-sg
2012年學術文章
@yue
2012年學術文章
@zh-hant
name
Granulocyte-macrophage colony- ...... flammatory and arthritic pain.
@en
Granulocyte-macrophage colony- ...... flammatory and arthritic pain.
@nl
type
label
Granulocyte-macrophage colony- ...... flammatory and arthritic pain.
@en
Granulocyte-macrophage colony- ...... flammatory and arthritic pain.
@nl
prefLabel
Granulocyte-macrophage colony- ...... flammatory and arthritic pain.
@en
Granulocyte-macrophage colony- ...... flammatory and arthritic pain.
@nl
P2093
P1476
Granulocyte-macrophage colony- ...... flammatory and arthritic pain.
@en
P2093
Andrew D Cook
Derek C Lacey
Jarrad Pobjoy
John A Hamilton
Manuela Dürr
Shannon Sarros
Stefan Steidl
P304
P356
10.1136/ANNRHEUMDIS-2012-201703
P407
P577
2012-07-24T00:00:00Z